The Role of Peroxisome Proliferator-Activated Receptors in Preeclampsia
Cells · 2023
DOI: 10.3390/cells12040647 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Cells, 2023. Verfasst von Iason Psilopatis und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Diagnostic and Interventional Radiology, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-…. Hauptthemen laut MEDLINE: Peroxisome Proliferator-Activated Receptors, Pre-Eclampsia. Die Arbeit wurde bisher 22-mal zitiert (Crossref) und nennt 114 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Preeclampsia is a common pregnancy-related hypertensive disorder. Often presenting as preexisting or new-onset hypertension complicated by proteinuria and/or end-organ dysfunction, preeclampsia significantly correlates with maternal and perinatal morbidity and mortality. Peroxisome proliferator-activated receptors (PPARs) are nuclear receptor proteins that regulate gene expression. In order to investigate the role of PPARs in the pathophysiology of preeclampsia, we conducted a literature review using the MEDLINE and LIVIVO databases. The search terms “peroxisome proliferator-activated receptor”, “PPAR”, and “preeclampsia” were employed and we were able to identify 35 relevant studies published between 2002 and 2022. Different study groups reached contradictory conclusions in terms of PPAR expression in preeclamptic placentae. Interestingly, PPARγ agonists alone, or in combination with well-established pharmaceutical agents, were determined to represent novel, potent anti-preeclamptic treatment alternatives. In conclusion, PPARs seem to play a significant role in preeclampsia.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Diagnostic and Interventional Radiology, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Augustenburger Platz 1, 13353 Berlin, Germany.
- First Department of Pathology, Medical School, National and Kapodistrian University of Athens, 75 Mikras Asias Street, Bld 10, Goudi, 11527 Athens, Greece.
- BIH Charité Clinician Scientist Program, Berlin Institute of Health at Charité-Universitätsmedizin Berlin, BIH Biomedical Innovation Academy, 10117 Berlin, Germany.
ORCID-Profile: Iason Psilopatis
Zitieren
APA
Psilopatis, I., Vrettou, K., Fleckenstein, F. N., & Theocharis, S. (2023). The Role of Peroxisome Proliferator-Activated Receptors in Preeclampsia. Cells. https://doi.org/10.3390/cells12040647
Vancouver
Psilopatis I, Vrettou K, Fleckenstein FN, Theocharis S. The Role of Peroxisome Proliferator-Activated Receptors in Preeclampsia. Cells. 2023. doi:10.3390/cells12040647
BibTeX
@article{Psilopatis2023,
author = {Psilopatis, Iason and Vrettou, Kleio and Fleckenstein, Florian Nima and Theocharis, Stamatios},
title = {The Role of Peroxisome Proliferator-Activated Receptors in Preeclampsia},
journal = {Cells},
year = {2023},
doi = {10.3390/cells12040647}
}
EUVIMED